Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients
Clinical trial NCT06606093 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06606093
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-23
- Primary completion
- 2026-09-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.